21 completed, 3 terminated, 2 recruiting, 1 not yet recruiting. 28 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 28 | Completed 21, Terminated 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1 |
Follow FluMist: new trials by email Literature Review of FluMist trials Research Report on FluMist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| How Healthy Adults Respond to the Nasal Flu Vaccine FluMist (Live Attenuated Influenza Vaccine) - Mucosal Immune Response to Influenza Vaccination | Phase 4 | Not yet recruiting | University of Alabama at Birmingham | 20 | 2026-12-01 | 2026-10-13 |
| Woodsmoke Exposure, Influenza Infection, and Nasal Immunity LAIV nasal vaccine is chosen as a model viral infection, Wood smoke, Placebo for LAIV nasal vaccine is chosen as a model viral infection - Smoke Exposure, Influenza | Phase 4 | Recruiting | University of North Carolina, Chapel Hill | 112 | 2025-09-26 | 2026-04-30 |
| Characterizing the Human Airway Immune Response to FluMist Vaccination FluMist, inactivated influenza vaccine, bronchoscopy - Healthy Young Adults, Influenza Vaccines | Phase 4 | Recruiting | Washington University School of Medicine | 30 | 2025-09-09 | 2025-09-17 |
| Revealing Protective Immunity to Influenza Using Systems Immunology Live Attenuated Influenza Vaccine - Influenza | Phase 4 | Completed | Emory University | 51 | 2024-10-14 | 2026-03-30 |
| Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood FluMist - Influenza | Phase 4 | Withdrawn | Stanford University | 2019-04-15 | 2023-11-21 | |
| Safety of Nasal Influenza Immunisation in Children With Asthma Administration of Live attenuated influenza vaccine (LAIV) - Asthma | Phase 4 | Completed | Imperial College London | 479 | 2016-10-01 | 2019-05-10 |
| Efficacy & Safety of Nasal Influenza Immunisation in Children Live attenuated influenza vaccine, Surveillance (nasal swabbing) during influenza season - Influenza Vaccines Efficacy and Safety | Phase 4 | Completed | Imperial College London | 276 | 2015-10-01 | 2019-12-11 |
| Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032) Fluzone®, FluMist® - Influenza | Phase 4 | Terminated | Stanford University | 3 | 2015-09-01 | 2017-05-10 |
| The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study Study one: LAIV + Inoculation, Study one: Placebo + Inoculation, Study two: Inoculation + LAIV - Pneumonia, Influenza, Human | Phase 4 | Completed | Liverpool University Hospitals NHS Foundation Trust | 324 | 2015-08-01 | 2018-04-18 |
| Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031) Fluzone®, FluMist® - Influenza | Phase 4 | Terminated | Stanford University | 10 | 2014-11-19 | 2017-09-12 |
| Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029) Fluzone®, FluMist® - Influenza | Phase 4 | Completed | Stanford University | 77 | 2014-09-17 | 2018-12-14 |
| Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents LAIV, IIV - Immune Response to Influenza Vaccine, Influenza A Virus Infection | Phase 4 | Completed | Marshfield Clinic Research Foundation | 131 | 2014-09-01 | 2018-04-26 |
| The Human Mucosal Immune Responses to Influenza Virus (SLVP026) Fluzone®, FluMist® - Influenza | Phase 4 | Completed | Stanford University | 13 | 2012-12-01 | 2017-04-21 |
| T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012 TIV, High-Dose TIV, LAIV - Influenza | Phase 4 | Completed | Stanford University | 22 | 2012-10-01 | 2017-05-22 |
| Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024) FluMist® - Influenza | Phase 4 | Completed | Stanford University | 18 | 2012-10-01 | 2021-10-18 |
| Self-Administered Nasal Influenza Feasibility Study FluMist - Influenza | Phase 4 | Completed | Henry M. Jackson Foundation for the Advancement of Military Medicine | 1077 | 2012-09-01 | 2023-02-15 |
| Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children Live attenuated Influenza vaccine, Trivalent Influenza Vaccine, TIV followed by LAIV - Influenza | Phase 4 | Completed | University of Rochester | 34 | 2010-10-01 | 2016-12-29 |
| B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011) Fluzone, FluMist - Influenza | Phase 4 | Completed | Stanford University | 91 | 2010-09-01 | 2018-06-06 |
| Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants Live attenuated influenza vaccine, Inactivated influenza vaccine - Influenza | Phase 4 | Terminated | University of Rochester | 3 | 2010-08-01 | 2014-08-22 |
| T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009 Fluzone® (intramuscular), FluMist® (intranasal) - Influenza | Phase 4 | Completed | Stanford University | 72 | 2009-09-01 | 2017-05-12 |
Showing 20 of 28. Sign in to see all of them.
Influenza, Human (24) · Asthma (1) · Pneumonia (1) · Premature Birth (1) · Sleep Apnea, Obstructive (1)
Stanford University (9) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Imperial College London (2) · MedImmune LLC (2) · University of Rochester (2) · Baylor College of Medicine (1) · Emory University (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Liverpool University Hospitals NHS Foundation Trust (1) · Marshfield Clinic Research Foundation (1) · The University of Hong Kong (1) · University of Alabama at Birmingham (1) · University of Michigan (1) · University of North Carolina, Chapel Hill (1) · Washington University School of Medicine (1)
United States (18) · United Kingdom (2) · Hong Kong (1)
Cornelia Dekker, MD (7) · Harry Greenberg, MD (4) · Xiaosong He, PhD (4) · Mark Davis, PhD (3) · Stephen Quake, PhD (3) · Ann Arvin, MD (2) · Garry Nolan, PhD (2) · Paul J Turner (2) · Robert Walker, MD (2) · Arnold S. Monto, MD (1) · Benjamin J Cowling, PhD (1) · Carl T. D'Angio, MD (1) · Cornelia L Dekker, MD (1) · Daniel Graciaa, MD, MPH, MSc (1) · Edward A Belongia, MD (1)
PMID 12915495, PMID 14706961, PMID 15694506, PMID 16140685, PMID 17167135, PMID 17395338, PMID 17698577, PMID 18401289, PMID 19776407, PMID 21028955, PMID 21378375, PMID 21998477, PMID 25165161, PMID 25858957, PMID 26117150, PMID 28963118, PMID 29706550, PMID 31117986, PMID 31642899, PMID 35139037
U19AI057229 (8), 2015 (1), 2016 (1), R01AI041050 (1), R01ES036209 (1), U19AI090019 (1)